newsfilter
← Latest News
FDA Approved Drugs·

Approval of Olpruva, Nda #214860 (Type 5 - New Formulation or New Manufacturer)

Approval Date: 12/22/2022; Drug Name: Olpruva, Nda #214860; Active Ingredients: SODIUM PHENYLBUTYRATE; Company: Acer Therapeutics Inc; Submission Status: Approval; Submission Classification: Type 5 - New Formulation or New Manufacturer; Application Number: 214860

Company
ACER THERAPEUTICS INC
Keywords
ACER THERAPEUTICS INC